ANNEE 2018
Publié le 16/01/2020 à 10h51 (mis à jour le 16/01/2020 à 12h08)
Bouvenot G, Sassard J, Montastruc JL. Pour une utilisation optimale des associations fixes de médicaments. Recommandations de prescription. Bull. Acad. Natle Méd. 2017 ;201,41-44.
El Chaer G, Lapeyre Mestre M. Tramadol : la crise des opioïdes de l’Afrique. Revue Prescrire. 2018 ;418:631.
Kaguelidou F, Kassai Koupai B, Durrieu G. Pediatric pharmacology.Therapie. 2018 ;73:111-112.
Montastruc F, Benevent J, Touafchia A, Chebane L, Araujo M, Guitton-Bondon E, Durrieu G, Arbus C, Schmitt L, Begaud B, Montastruc JL. Atropinic (Anticholinergic) Burden in Antipsychotic-Treated Patients. Fundam Clin Pharmacol. 2018 ;32:114-119.
Montastruc F, Bagheri H, Lacroix I, Damase-Michel C, Chebane L, Rousseau V, Jouanjus E, Lapeyre-Mestre M, Durrieu G, Montastruc JL. Adverse Drug Reaction Reports Received Through the Mobile App, VigiBIP® : A Comparison with Classical Methods of Reporting. Drug Saf. 2018 ;41:511-514.
Montastruc F, Benevent J, Rousseau V, Durrieu G, Sommet A, Montastruc JL. Risk of Diabetes with Fibrates and Statins : a pharmacoepidemiological study in Vigibase®. Fundam Clin Pharmacol. 2018 Aug 11. doi : 10.1111/fcp.12406. [Epub ahead of print]
Montastruc F, Benevent J, Chebane L, Rousseau V, Durrieu G, Sommet A, Montastruc JL. Vomiting and constipation associated with tramadol and codeine : a comparative study in VigiBase®. Eur J Clin Pharmacol. 2018 Aug 10. doi : 10.1007/s00228-018-2536-z. [Epub ahead of print].
Montastruc F, Khosrow-Khavar F, de Germay S, Renoux C, Rousseau V, Durrieu G, Montastruc M, Rascol O, Sommet A, Lapeyre-Mestre M, Benevent J, Montastruc JL. Tamoxifen and the risk of Parkinsonism : a case/non-case study. Eur J Clin Pharmacol. 2018 ;74:1181-1184.
Moulis F, Rousseau V, Chebane L, Gouverneur A, Gaboriau L, Faillie JL, Durrieu G, Montastruc F, Montastruc JL. Serious adverse drug reactions with sacubitril/valsartan Entresto® : a French pharmacovigilance survey. Eur J Clin Pharmacol. 2018 ;74:983-84.
Moulis F, Durrieu G, Masmoudi K, Gervoise Boyer M, Rocher F, Montastruc F, Montastruc JL. Medication errors with tramadol drops in children. Eur J Clin Pharmacol. 2018 ;74:247-248.
Moulis F, Durrieu G, Lapeyre-Mestre M. Off-label and unlicensed drug use in children population. Therapie. 2018 ;73:135-149.
Nguyen TTH, Roussin A, Rousseau V, Montastruc JL, Montastruc F. Role of Serotonin Transporter in Antidepressant-Induced Diabetes Mellitus : A Pharmacoepidemiological–Pharmacodynamic Study in VigiBase. Drug Safety. 2018. https://doi.org/10.1007/s40264-018-0693-8
Nguyen KD, Nguyen PT, Nguyen HA, Roussin A, Montastruc JL, Bagheri H, Olsson S. Overview of Pharmacovigilance System in Vietnam : Lessons Learned in a Resource-Restricted Country. Drug Saf. 2018 ;41:151-159.
Perez C, Olivier P, Lortal B, Duranton S, Montastruc JL, Colin AL, Toulza E, Becker M, Hamy L, Crepin S, Roussillon C, Gimbert A, Petitpain N, Salvo F. Detection of drug safety signals from clinical trials data : Role of SUSARs. Pharmacol Res. 2018 ;131:218-223.
Revet A, Montastruc F, Raynaud JP, MD, Baricault B, Montastruc JL, Maryse Lapeyre-Mestre M. Trends and Patterns of Antidepressant Use in French Children and Adolescents From 2009 to 2016. A Population-Based Study in the French Health Insurance Database. Journal of Clinical Psychopharmacology. 2018 ;38:327-335.
Reynolds E, Guénette L, Lexchin J, Cassels A, Wilkes MS, Durrieu G, Beaulieu MD, Mintzes B. Reconciling a "pleasant exchange" with evidence of information bias : A three-country study on pharmaceutical sales visits in primary care. Health Policy. 2018 ;122:250-255.
Rwagitinywaa J, Sommet A, Palmaro A, Montastruc JL, Lapeyre-Mestre M. Utilization and costs of HIV antiretroviral drugs in Europe during thelast ten years : Impact of generic antiretroviral drugs on cost reduction. Health Policy. 2018 ;122:237-242.
Rwagitinywa J, Lapeyre-Mestre M, Bourrel R, Montastruc JL, Sommet A. Comparison of adherence to generic multi-tablet regimens versus brand multi-tablet and brand single-tablet regimens likely to incorporate generic antiretroviral drugs by breaking or not fixed-dose combinations in HIV-infected patients. Fundam Clin Pharmacol. 2018 Mar 5. doi : 10.1111/fcp.12363. [Epub ahead of print]
Wadelius M, Eriksson N, Kreutz R, Bondon-Guitton E, Ibañez L, Carvajal A, Lucena MI, Sancho Ponce E, Molokhia M, Martin J, Axelsson T, Kohnke H, Yue QY, Magnusson PKE, Bengtsson M, Hallberg P ; EuDAC. Sulfasalazine-induced agranulocytosis is associated with the human leukocyte antigen locus. Clin Pharmacol Ther. 2017 Aug 1. doi : 10.1002/cpt.805. [Epub ahead of print]
Partager cette page